Viking North Ventures

Viking Global Investors is a leading global investment management firm that is a prolific investor in the life sciences and biotechnology sectors. Through its private equity and venture capital arms, including entities like Viking North Ventures, the firm provides late-stage venture and growth capital to innovative healthcare companies. Viking is recognized for its deep sector expertise and has been a key backer of numerous high-profile biotech firms, including Roivant Sciences, Moderna, and Adaptive Biotechnologies. Headquartered in Greenwich, Connecticut, the firm plays a pivotal role in funding innovation in drug discovery, diagnostics, and healthcare technology.